It summarizes the results of randomized trials, meta-analyses, and observational studies, and discusses the pharmacological differences among these angiotensin II receptor blockers
37% of reviewers reported a positive effect, while 37% reported a negative effect
But other research shows that olmesartan and losartan may be equally effective after a few months
In patients with higher uric acid levels, the ARB of choice should be
At these dose levels, olmesartan medoxomil was shown to be more effective than candesartan cilexetil in reducing daytime and 24-hour DBP and SBP assessed by ABPM, with significant between-group
Patients prescribed candesartan (8 mg once daily in the morning) or telmisartan (40 mg